Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Biesenbach, Peter ^a   Kain, Renate ^a   Derfler, Kurt ^a   Perkmann, Thomas ^a   Soleiman, Afschin ^a   Benharkou, Alexandra ^a   Druml, Wilfred ^a   Rees, Andrew ^a   Säemann, Marcus D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY; AUTOANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CREATININE BLOOD LEVEL; DIALYSIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY DISEASE; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; LONG TERM CARE; MALE; NECROTISING GLOMERULONEPHRITIS; NECROTIZING GLOMERULONEPHRITIS; OUTCOME ASSESSMENT; PLASMAPHERESIS; PROTEINURIA; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT DURATION; UNIVERSITY HOSPITAL; ADOLESCENT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BLOOD; ISOLATION AND PURIFICATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; FEMALE; HUMANS; MALE; PLASMAPHERESIS; YOUNG ADULT;

EID: 84905085483     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103568     Document Type: Article

References (29)

1. Turner N, Mason PJ, Brown R, Fox M, Povey S, et al. (1992) Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 89: 592-601.
2. Couser WG (1988) Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11: 449-464.
3. Andrassy K, Küster S, Waldherr R, Ritz E (1991) Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. Nephron 59: 206-212.
4. Heaf J, Løkkegaard H, Larsen S (1999) The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997. Nephrol Dial Transplant 14: 1889-1897. (Pubitemid 29358884)
5. Bolton WK (1996) Goodpasture's syndrome. Kidney Int 50: 1753-1766.
6. Madore F, Lazarus JM, Brady HR (1996) Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 7: 367-386. (Pubitemid 26128308)
7. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM (1986) Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed) 292: 301-304. (Pubitemid 16144622)
8. Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of antiglomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134: 1033-1042. (Pubitemid 32488657)
9. Jindal KK (1999) Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations. Kidney Int Suppl 70: S33-40.
10. Kaplan AA (2003) The use of apheresis in immune renal disorders. Ther Apher Dial 7: 165-172.
11. Cui Z, Zhao J, Jia XY, Zhu SN, Jin QZ, et al. (2011) Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore) 90: 303-311.
12. Biesenbach P, Schmaldienst S, Smolen JS, Hörl WH, Derfler K, et al. (2009) Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity. Atheroscler Suppl 10: 114-121.
13. Knöbl P, Derfler K, Korninger L, Kapiotis S, Jäger U, et al. (1995) Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb). Thromb Haemost 74: 1035-1038.
14. Schmaldienst S, Müllner M, Goldammer A, Spitzauer S, Banyai S, et al. (2001) Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases? Rheumatology (Oxford) 40: 513-521.
15. Pusey CD, Levy JB (2012) Plasmapheresis in immunologic renal disease. Blood Purif 33: 190-198.
16. Snyder HW Jr, Cochran SK, Balint JP Jr, Bertram JH, Mittelman A, et al. (1992) Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood 79: 2237-2245.
17. Kasperkiewicz M, Schmidt E, Zillikens D (2012) Current therapy of the pemphigus group. Clinics in dermatology 30: 84-94.
18. Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, et al. (1998) Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9: 1709-1715. (Pubitemid 28405079)
19. Schmaldienst S, Jansen M, Hollenstein U, Graninger W, Regele H, et al. (2002) Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis. Am J Kidney Dis 39: 415-418. (Pubitemid 34174267)
20. Stummvoll GH, Schmaldienst S, Smolen JS, Derfler K, Biesenbach P (2012) Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity. Nephrol Dial Transplant 27: 618-626.
21. Hu W, Liu Z, Ji D, Xie H, Gong D, et al. (2006) Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients. J Nephrol 19: 312-317. (Pubitemid 46785542)
22. Stegmayr BG, Almroth G, Berlin G, Fehrman I, Kurkus J, et al. (1999) Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs 22: 81-87. (Pubitemid 29158995)
23. Moreso F, Poveda R, Gil-Vernet S, Carreras L, García-Osuna R, et al. (1995) [Therapeutic immunoadsorption in Goodpasture disease]. Med Clin (Barc) 105: 59-61.
24. Laczika K, Knapp S, Derfler K, Soleiman A, Hörl WH, et al. (2000) Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis 36: 392-395. (Pubitemid 30485848)
25. Schmaldienst S, Goldammer A, Spitzauer S, Derfler K, Hörl WH, et al. (2000) Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption. Am J Kidney Dis 36: 490-497.
26. Peters DK, Rees AJ, Lockwood CM, Pusey CD (1982) Treatment and prognosis in antibasement membrane antibody-mediated nephritis. Transplant Proc 14: 513-521. (Pubitemid 13197323)
27. Pusey CD (2003) Anti-glomerular basement membrane disease. Kidney Int 64: 1535-1550.
28. Stummvoll GH, Aringer M, Jansen M, Smolen JS, Derfler K, et al. (2004) Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy. Wien Klin Wochenschr 116: 716-724. (Pubitemid 39647778)
29. Aringer M, Smolen JS, Graninger WB (1998) Severe infections in plasmapheresis-treated systemic lupus erythematosus. Arthritis Rheum 41: 414-420. (Pubitemid 28128765)